Cite Filings / IRD / 0001974078-26-000387
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Opus Genetics, Inc. · Filed 2026-10-23 · Acc 0001974078-26-000387

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-10-27 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-10-27 4 Chief Operating Officer sold 4,767 shares at $3.57 ($16,994)
  • 2026-10-27 4 President sold 33,189 shares at an average $3.54 ($117,365)
  • 2026-10-23 144 Sale of Securities
  • 2026-10-23 144 Sale of Securities
  • 2026-10-23 144 Sale of Securities
  • 2026-10-21 8-K Executive or director change

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…